Clinical Trial

A Phase I/II Study of CM355 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Name: A Phase I/II Study of CM355 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) — clinical trial record (NCT05210868)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

A Phase I/II Open-Label, Single-Arm, Multicenter Clinical Study of CM355 in Patients With R/R B-NHL

Trial Details

NCT Number	NCT05210868
Lead Sponsor	Beijing InnoCare Pharma Tech Co., Ltd.
Conditions	Hematoma
Enrollment	184 participants
Start Date	2021-11-16
Primary Completion	2026-12-28 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2022-01-27